RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Recurrence and survival predictive value of phenotypic expression of BCL2 varies with tumor stage of CRC adenocarcinomas
Chatla, C., Jhala, N., Katkoori, V., Alexander, D., Meleth, S., Grizzle, W., & Manne, U. (2005). Recurrence and survival predictive value of phenotypic expression of BCL2 varies with tumor stage of CRC adenocarcinomas. Cancer Biomarkers, 1(4-5), 241 - 250.